Genomatica Targets Natural Cosmetics and Personal Care with Daicel Partnership for Brontide Natural Butylene Glycol

Targeting fast growth to thousands of tons per year via exclusive agreement for Asia Pacific


SAN DIEGO and OSAKA, Japan, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Genomatica is meeting the fast-growing demand for natural personal care and cosmetics ingredients through a multi-year agreement with Daicel Corporation to be the exclusive distributor of its award-winning Brontide™ butylene glycol in the Asia-Pacific region. The companies anticipate Daicel’s purchases will quickly grow to thousands of tons of Brontide butylene glycol per year for its customers, leveraging Daicel’s established and respected presence in the Asian cosmetics market and enabling market expansion with this innovative product. This partnership further realizes both companies’ commitment to advancing sustainability and is consistent with Daicel’s objectives of Environmental Preservation and their participation in the Nippon Keidanren Commitment to a Low Carbon Society.

Brontide butylene glycol is a natural, sustainably-produced butylene glycol for use in personal care products – for moisture retention, improved texture, antimicrobial properties and as a solubilizer for plant extracts, flavors and fragrances. The ingredient is a drop-in replacement for petroleum-derived ingredients, enabling manufacturers to address consumer demand for natural personal care products without compromising on functionality or sensory appeal. Brontide butylene glycol is made using a direct fermentation process that starts with renewable, plant-derived sugars instead of crude oil.

Strong customer interest; fast-growing need
Daicel identified hundreds of potential Brontide butylene glycol customers during an initial marketing partnership between the companies and serviced over 100 inquiries and/or sample requests, confirming the high interest in natural ingredients. 75% of millennial and Gen Z consumers believe natural skincare products are more effective, according to a report by Compose[d] Creative, a digital agency. And, according to Ecovia Intelligence, a market research firm, natural and organic cosmetics sales increased by 21% in Asia in 2017.

“Brontide is the first widely-available product that allows personal care manufacturers to use butylene glycol in natural or plant-based formulations,” said Hitoshi Hayashi, Daicel’s executive officer, company president of Organic Chemical Products Company. “Brontide natural butylene glycol complements our existing butylene glycol products and gives our customers a new way to increase the performance of their natural personal care formulations. Daicel anticipates that bio-based and naturally-sourced products will be increasingly important.”

"Our partnership with Daicel paves the way for rapid growth of Brontide in this key geographic market," said Damien Perriman, Genomatica’s senior vice president, Specialty Chemicals. “Daicel’s expertise in the personal care and butylene glycol markets enables us to immediately help manufacturers meet rising consumer demand for natural products in Asia Pacific.”

To request a product sample or learn more, contact Daicel at yuki@jp.daicel.com or Genomatica at Brontide@genomatica.com and visit www.brontidebg.com.

About Genomatica
Genomatica is a widely-recognized leader in bioengineering and aims to lead a transition to more sustainable materials. It develops bio-based process technologies that enable a better way to produce widely-used chemicals, from alternative feedstocks, with better economics, sustainability and performance. Genomatica has commercialized processes for the chemical butanediol (for biodegradable plastics and apparel) and for butylene glycol (cosmetics and personal care); and is working on bio-nylon. Awards include the Kirkpatrick Award, for “the most noteworthy chemical engineering technology commercialized in the world” and the ICIS Innovation Award for its Brontide butylene glycol. To learn more, visit www.genomatica.com or www.brontidebg.com.

About Daicel
Daicel Corp. (TSE: 4202), headquartered in Osaka, Japan, contributes to an improved quality of life by meeting the needs of society. The company’s consolidated revenues for fiscal 2018 (ended March 31, 2019) totaled 464.9 billion yen ($4.3 billion). The Daicel Group takes pride in providing the best solutions based on our unique technologies, including cellulose chemistry, organic chemistry, polymer chemistry, and pyrotechnic engineering with approximately 12,000 employees worldwide. For more information on Daicel, please visit the company's website at https://www.daicel.com/en.

For more information
For Genomatica: Patti Bianchi, pbianchi@cglife.com, +1.630.841.1771
For Daicel: Koichiro Nishioka, yuki@jp.daicel.com, +81.3.6711.8213